Cantor Fitzgerald provides analyst ratings and price targets for Paychex, while also disclosing holdings changes with the SEC.
1 report, 1 independent
Updated Aug 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald provides analyst ratings and price targets for Paychex, while also disclosing holdings changes with the SEC.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cantor Fitzgerald
American financial services company
-
Paychex
American company
-
SEC
Slovak company
Related events
- Cantor Fitzgerald raised its price target and rating, while Bank of America adjusted its rating and price target, with MarketBeat aggregating the stock rating data.
- An unnamed company is facing analyst raises and price target increases from Morgan Stanley, Keefe, Bruyette & Woods, and Cantor Fitzgerald, leading to insider trading disclosures to the SEC.
- Analyst rating targets influenced the stock price of Hudson Pacific Properties.
- Cantor Fitzgerald raised its price target and rating for Supernus Pharmaceuticals, Inc. on September 2, 2026, and the company filed a disclosure with the SEC.
- Moderna stock activity, including institutional purchases and analyst ratings, was disclosed to the SEC.